Clinical trial
A Clinical Utility Study of PrismRA Testing Therapeutic Response for Rheumatoid Arthritis (DRIVE)
NCT05161234 is registered in ClinicalTrials.gov with Scipher Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Utility Study of PrismRA Testing Therapeutic Response for Rheumatoid Arthritis (DRIVE)
- Lead sponsor
- Scipher Medicine
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 3, 2022
- Completion date
- December 6, 2023
- Enrollment
- 613 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis